Hence then, the article about kintor pharma announces completion of patient enrollment in phase ii clinical trial of gt20029 for treatment of androgenetic alopecia in china was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China )
Last updated :
Also on site :
- JP Morgan Chase head warns of unexpected interest rate shocks as a result of Iran war
- AI startup Rocket offers vibe McKinsey-style reports at a fraction of the cost
- Thousands of Americans Face New IRS Deadline to Avoid Penalties